We serve Chemical Name:2-(Ethoxymethyl)-1-methyl-1H-benzimidazole CAS:27243-70-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(Ethoxymethyl)-1-methyl-1H-benzimidazole
CAS.NO:27243-70-5
Synonyms:2-ethoxymethyl-1,2-benzisothiazoline-3-oxo-1,1-dioxide;2-Aethoxymethyl-1-methylbenzimidazol;1-methyl-2-ethoxymethylbenzimidazole;2-ethoxymethyl-1-methyl-1H-benzoimidazole;N-Aethoxymethyl-saccharin
Molecular Formula:C11H14N2O
Molecular Weight:190.24200
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:27.05000
Exact Mass:190.11100
LogP:2.10980
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-ethoxymethyl-1,2-benzisothiazoline-3-oxo-1,1-dioxide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Aethoxymethyl-saccharin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-ethoxymethyl-1-methyl-1H-benzoimidazole Use and application,2-Aethoxymethyl-1-methylbenzimidazol technical grade,usp/ep/jp grade.
Related News: The Lonza team also contains regulatory specialists with experience working with Chinese regulators throughout the drug development and scale-up process. Approximately 250 employees work at Lonza’s Nansha site; this expansion is expected to create around 70 new positions. 4-Oxo-3,5-diphenyl-cyclopent-2-ene-1,1,2-tricarbonitrile manufacturers Jan Vertommen, Senior Director, Commercial Development, Lonza, said, “Increasing our capabilities by adding mid-scale API manufacturing at our site in Nansha will benefit our customers, and especially the many global emerging biotech companies we partner with. Ethyl 2-chloro-2-dodecenate suppliers The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). Butanedioic acid, (phenylacetyl)-, 1-(1,1-dimethylethyl) 4-ethyl ester vendor & factory.
